Thomas “Rock” Mackie, director of medical engineering at the Morgridge Institute for Research, will receive the highest honor in the field of medical physics for his game-changing contributions to medical imaging.
Located at 1401 University Avenue (one block west of Wisconsin Institutes for Discovery), we offer entrepreneurs the opportunity to participate in a summer accelerator program that can provide up to $10,000 in funding as you and your team seek commercial viability for your endeavor. Our summer accelerator is based on best practices of lean start-up. […]
Illumina, the global leader in genomic sequencing, is expanding its presence in Madison through increased funding of Epicentre, acquired in 2011 and located at University Research Park.
The National Institutes of Health (NIH) has partnered with the Biotechnology Industry Organization (BIO) to provide selected SBIR grantees premier visibility at the BIO International Convention. InvivoSciences (IVS) is one of the selected NIH Innovation Zone companies interacting with potential investors and business partners. BIO International Convention is the world’s largest conference, attracting 15,000 biotech […]
Exact Sciences Corp. announced that the U.S. Food and Drug Administration’s (FDA) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee determined by a unanimous vote that Exact Sciences has demonstrated safety, effectiveness and a favorable risk benefit profile of Cologuard ®, the company’s stool-based DNA (sDNA), non-invasive colorectal cancer screening test. Read […]
Exact Sciences, located at URP, successfully cleared another hurdle in the rollout of its Cologuard product, a non-invasive screening test for colorectal cancer. Next week, an FDA panel will review Exact Sciences’ pre-market approval application. Read more
Cellular Dynamics reports an 81% increase in total revenues and an 87% increase in average sales to its top 10 customers during fiscal year 2013. Read more
A new project, involving a partnership between the Morgridge Institute, UW-Madison, Indiana University and the University of Illinois, aims to root out software vulnerabilities that can leave the door open for viruses, website hacking or other forms of cybercrime, ?estimated as a $100 billion industry. Read more
A $10.6 million, five-year EPA contract for Stemina Biomarker Discovery, announced this week, doesn’t just provide a new source of revenue. It also holds the potential to make the Madison company’s technology a standard for testing chemicals and drugs for their toxic effects, long-term, CEO Elizabeth Donley said.Read more
Cary, NC – November 17, 2013. BMG LABTECH, Inc. – the Microplate Reader Company – and InvivoSciences, Inc. – a leader in stem cell tissue engineering providing a novel solution in first-in-class drug discovery – announced today a strategic collaboration to market the time-dependent fluorescent assessment of engineered 3D heart tissues using advanced microplate reader […]